These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 11190124)
61. Final regulations amending basic HHS policy for the protection of human research subjects--Department of Health and Human Services. Final rule. Fed Regist; 1981 Jan; 46(16 Pt 2):8366-91. PubMed ID: 10249932 [TBL] [Abstract][Full Text] [Related]
62. Protecting human research subjects: ten common problems. Puglisi T Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046 [No Abstract] [Full Text] [Related]
63. Protection of human subjects: proposed regulations on research involving prisoners. Fed Regist; 1978 Jan; 43(3):1049-53. PubMed ID: 10306149 [No Abstract] [Full Text] [Related]
64. Bioethical malpractice: risk and responsibilities in human research. Noah BA J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441 [No Abstract] [Full Text] [Related]
65. Agency drops requirement for IRB approval of changes. Maloney DM Hum Res Rep; 1999 Feb; 14(2):3. PubMed ID: 11657604 [No Abstract] [Full Text] [Related]
66. University later admits that regulations were not followed. Maloney DM Hum Res Rep; 2002 Feb; 17(2):6-7. PubMed ID: 12374176 [No Abstract] [Full Text] [Related]
67. Federal report says protection of human subjects is threatened by numerous factors. Maloney DM Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438 [No Abstract] [Full Text] [Related]
68. Regulations, ethics, and research with children. Maloney DM Hum Res Rep; 2004 Apr; 19(4):3. PubMed ID: 15462033 [No Abstract] [Full Text] [Related]
69. Medical and psychological experimentation on California prisoners. Herch F; Flower R Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107 [No Abstract] [Full Text] [Related]
70. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration. Bramstedt KA; Kassimatis K Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112 [TBL] [Abstract][Full Text] [Related]
71. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. Kipnis K; King NM; Nelson RM IRB; 2006; 28(2):16-9. PubMed ID: 16770884 [No Abstract] [Full Text] [Related]
72. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
73. Multicenter trials and subject eligibility: should local IRBs play a role? Freedman B IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320 [No Abstract] [Full Text] [Related]
74. Informed consent: the FDA's perspective. Bagley G Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141 [No Abstract] [Full Text] [Related]
76. Guide to decision-making in institutional review of proposals for human experimentation: commentary. George R Man Med; 1978; 3(3):210-2. PubMed ID: 10316737 [No Abstract] [Full Text] [Related]
77. When informed consent is not required in studies. Maloney DM Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532 [No Abstract] [Full Text] [Related]
78. Can (or should) the IRB assume the FDA's functions at early stages of the IND process? Levine RJ IRB; 1981 Dec; 3(10):4-5. PubMed ID: 11649414 [No Abstract] [Full Text] [Related]
79. Investigational drugs and research. Tueting P Psychiatr Med; 1991; 9(2):333-47. PubMed ID: 1857767 [TBL] [Abstract][Full Text] [Related]
80. IRB review of a Phase II randomized clinical trial involving incompetent patients suffering from severe closed head injury. Prentice ED; Antonson DL; Leibrock LG; Kelso TK; Sears TD IRB; 1993; 15(5):1-7. PubMed ID: 11659703 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]